Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a zappy headband cure lazy eye? new trial hopes so

NCT ID NCT07547670

Symptom relief Sponsor: Universidad de Murcia Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jul 29, 2026 · Updated 3 times

Summary

This study tests whether a non-invasive brain stimulation technique called tDCS can safely improve vision in 100 children aged 4-14 with lazy eye (amblyopia) that hasn't improved with standard patching. Children will receive either real or sham tDCS over three sessions, and their vision will be measured before, after, and up to three months later. The goal is to see if this device can boost visual recovery by enhancing brain plasticity.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
transcranial direct current stimulation (tDCS) device
What this could lead to
If it works, this could offer a non-invasive, child-friendly way to improve vision in children with lazy eye who haven't benefited from patching.
What could go wrong
This is an early-stage trial with only 100 participants and no phase designation. The treatment is short-term (3 sessions), so lasting benefits are uncertain. Mild side effects from brain stimulation are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Aug 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

4 to 14 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children aged 4-14 years. * Strabismic amblyopia resistant to patching (PEDIG criteria). * Anisometropic amblyopia resistant to patching (PEDIG criteria). Exclusion Criteria: * Ocular pathology. * Nystagmus. * Mental disability. * Cognitive delay. * Neurological problems incompatible with treatment. * Pacemakers. * Intracranial electrodes. * Implanted defibrillators. * Cranial pathologies. * Cranial lesions. * Withdrawal will occur upon adverse events, protocol deviation, refusal, or loss to follow-up.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Amblyopia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

amblyopia suppression amblyopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Amblyopia Amblyopia strabismic Stereoscopic vision Visual acuity

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Murcia

    RECRUITING

    Murcia, 30100, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.